IRNDP Conference 2019

IRNDP held its first conference on the 14th and 15th of October, 2019 in Sydney.  A big thank you to everyone who attended! There was a fantastic range of speakers from the United States, Canada, Sweden, Thailand, Malaysia and Australia and a massive spread of 140 registered delegates from Denmark, Canada, United States, Sweden, Malaysia, Bangladesh, Thailand Read more…

IRNDP Special Issue

We are delighted to announce that the fully open access IRNDP special issue of the Journal of Alzheimer’s Disease has now been released. The special issue focuses exclusively on dementia prevention and represents a substantial and wide ranging collection of evidence. The issue draws together articles and commentaries from members Read more…

From Cell Culture to Populations: Evidence that a group of pain-relievers slow Alzheimer’s disease progression

New research has come out showing that a group of nonsteroidal anti-inflammatory drugs (NSAID) may have therapeutic effects for Alzheimer’s Disease. Dr Jack Rivers-Auty and his team have been investigating the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) in reducing neuroinflammation. Using mice models Jack and his team have found that the Read more…

Infographics on dementia risk factors now available in multiple languages

We are delighted to announce that we now have infographics available to illustrate the main modifiable risk factors for dementia available in multiple languages including Spanish and Mandarin.  Thanks are due to the Australian National Health and Medical Research Council National Institute for Dementia Research (NNIDR)  Dementia Centre for Research Collaboration for Read more…